Login Register
icon_bulk_orderBulk order Acrobiosystems for English
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > GITR


Brief Information

Name:Glucocorticoid-induced tumor necrosis factor receptor-related protein
Target Synonym:TNFRSF18,TNF Receptor Superfamily Activation-Inducible Protein,ENERGEN,GITR-D,Tumor Necrosis Factor Receptor Superfamily Member 18,CD357 Antigen,Activation-Inducible TNFR Family Receptor,AITR,CD357,GITR,Glucocorticoid-Induced TNFR-Related Protein,Tumor Necrosis Factor Receptor Superfamily, Member 18,TNF Receptor Superfamily Member 18
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:8
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Part of Bioactivity data

Canine GITR, His TagCanine GITR, His Tag (Cat. No. GIR-C52H6) ELISA bioactivity

Immobilized Canine GITR, His Tag (Cat. No. GIR-C52H6) at 2 μg/mL (100 μL/well) can bind Human GITR Ligand, Fc Tag (Cat. No. GIL-H526a) with a linear range of 2-40 ng/mL (QC tested).

Biotinylated Human GITR, His,Avitag™ (Cat. No. ) MALS images

The purity of Biotinylated Human GITR, His,Avitag™(Cat. No. GIR-H82E1) is more than 95% and the molecular weight of this protein is around 20-30 kDa verified by SEC-MALS.

Biotinylated Human GITR, His,Avitag™Biotinylated Human GITR, His,Avitag™ (Cat. No. GIR-H82E1) ELISA bioactivity

Immobilized Human GITR Ligand, Fc Tag (Cat. No. GIL-H5261) at 10 μg/mL (100 μL/well) can bind Biotinylated Human GITR, His,Avitag (Cat. No. GIR-H82E1) with a linear range of 0.2-8 ng/mL (QC tested).

Customer Reviews

Synonym Name



Glucocorticoid-induced TNFR-related protein (GITR) is also known as Tumor necrosis factor receptor superfamily member 18 (TNFRSF18), activation-inducible TNFR family receptor (AITR), CD antigen CD357, which is a member of the tumor necrosis factor receptor (TNF-R) superfamily. GITR is receptor for TNFSF18, which seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. GITR also mediated NF-kappa-B activation via the TRAF2/NIK pathway.

Clinical and Translational Updates

Related Molecule

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Anti-GITR antibody (BMS) Phase 1 Clinical Neoplasms Details
GWN-323 GWN-323 Novartis Pharma Ag Details
REGN-6569 REGN6569; REGN-6569 Regeneron Pharmaceuticals Details
Ragifilimab INCAGN-1876; INCAGN-01876; AGEN-1876; CM-701 Agenus Inc, Ludwig Institute For Cancer Research Details
AMG-228 AMG-228 Amgen Inc Details
OMP-336B11 OMP-336B11 Oncomed Pharmaceuticals Inc Details
MK-1248 MK-1248 Merck Sharp & Dohme Corp Details
BMS-986156 BMS-986156 Phase 2 Clinical Bristol-Myers Squibb Company Solid tumours; Neoplasms Details

This web search service is supported by Google Inc.

Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message